Company Search:
Advanced Search
Sponsored Links
Morepen Laboratories Limited Company Snapshot
Morepen Laboratories Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Morepen Laboratories Limited with three other companies in this sector in India: Astrazeneca Pharma India Ltd (2017 sales of 5.40 billion Indian Rupees [US$83.20 million] of which 96% was Healthcare), Neuland Laboratories Limited (5.73 billion Indian Rupees [US$88.32 million] of which 100% was Bulk Drugs), and Suven Life Sciences Limited (5.44 billion Indian Rupees [US$83.81 million] of which 95% was Intermediaries under Contract Research/M).

Sales Analysis. Morepen Laboratories Limited reported sales of 5.84 billion Indian Rupees (US$90.04 million) for the fiscal year ending March of 2017. This represents an increase of 20.4% versus 2016, when the company's sales were 4.85 billion Indian Rupees. Sales at Morepen Laboratories Limited have increased during each of the previous five years (and since 2012, sales have increased a total of 108%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Morepen Laboratories Limited
  Stock Performance Chart for Morepen Laboratories Limited
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 33.30
(Figures in Indian Rupees)
1 Week 4.7%   13 Weeks -6.5%  
4 Weeks 32.7%   52 Weeks 63.6%  
Morepen Laboratories Limited Key Data:
  Ticker: MOREPENLAB Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 5,839,020,000
(Year Ending Jan 2018).
Employees: 1,085
  Currency: Indian Rupees Market Cap: 14,979,212,560
  Fiscal Yr Ends: March Shares Outstanding: 449,826,203
  Share Type: Ordinary Closely Held Shares: 205,092,571
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.